05.21.14
The Hartmann Group continued its profitable growth in the first quarter of 2014, despite the strong price pressures from customers and the depreciation of many currencies against the euro. The Heidenheim-based medical device manufacturer increased worldwide sales by 2.9% to €450.2 million ($619 million). When adjusted for exchange-rate and acquisition effects, EBIT rose by 10.5% to €33.3 million ($45.8 million). In wound management, sales increased 3.2% to €95.5 million ($131 million) while organic growth was 4.5%. Meanwhile, in incontinence management, sales were €152.8 million ($210 million), remaining at about last year’s level. MoliCare Mobile, the incontinence pants for mobile patients and Menalind professional, the skin care range for irritated, mature skin, delivered a good sales performance. Sales in the Infection Management segment improved by 1.3% to €108.9 million ($149.8 million).